Oct 31, 2019 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Valneva 9-Month 2019 Financial Results Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Thursday, 31st of October 2019.
I would now like to hand the conference over to your speaker today, Thomas Lingelbach. Please go ahead, sir.
Thomas Lingelbach - Valneva SE - Chairman of the Management Board, President & CEO
Thank you so much. Good day to everyone. It's a pleasure for us to present today our 9-month 2019 financial results and to give you some updates on our strong R&D execution and general business.
With that, let me draw your attention to Page #4 of the presentation. So first of all, of course, the biggest news of the day is that we have raised our 2019 full year product sales guidance following a strong 9-month result and, more importantly, even we have to report nice and significant R&D milestones and progression.
On our lead program in R&D, our Lyme vaccine, which is the only clinical-stage
Nine Months 2019 Valneva SE Earnings Call Transcript
Oct 31, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers